NEU neuren pharmaceuticals limited

Ann: Patent to 2034 granted in Europe for Neuren's NNZ-2591, page-15

  1. 205 Posts.
    lightbulb Created with Sketch. 70
    Shares were consolidated 1 for 20. So, to put it simply :
    if your late father bought 20 share originally, there would now be 1 share.
    So for example, if he paid 15 cents / share originally, the total cost of 20 shares would have been 15c x 20 = 300 cents ($3.00) (the cost-base). Today (after consolidation) 1 share would be $3.00 (the cost base)

    Professional investors also consider the 'time cost' of money and (annual) returns related to the risk associated with an investment's asset class.
    Early stage biotech's are generally high risk and therefore should have the potential to yield multiples of funds invested at an early stage. Someone experienced in such investment should be able to help if needed.

    Not professional advice; please do your own DD

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.85
Change
-0.110(0.85%)
Mkt cap ! $1.598B
Open High Low Value Volume
$12.82 $13.05 $12.53 $6.559M 511.8K

Buyers (Bids)

No. Vol. Price($)
1 1657 $12.83
 

Sellers (Offers)

Price($) Vol. No.
$12.85 6303 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.